OpenVSafe by OpenVAERS
Search V-safe

T5U-19966-64270

3 vaccinations 1 coded response 3 check-ins 1 free-text entry 1 call case
Sex
Female
Age at first dose
36-40
ZIP prefix
080 / NJ
Registered
2021-01-08
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-01-08
    Registered in v-safe
  2. 2021-01-08
    Dose 1 — Pfizer-BioNTech
  3. 2021-01-29
    Dose 2 — Pfizer-BioNTech
  4. 2021-10-01
    Dose 3 — Pfizer-BioNTech
  5. 2021-10-01
    Health check-in — day 0, dose 3
    Feeling: Fair · Headache, Fatigue or tiredness
    Adult check-in
  6. 2021-10-08
    Health check-in — day 7, dose 3
    Feeling: Good · None
    Adult check-in
  7. 2022-10-01
    Survey response — 12 months, dose 3
    MedDRA: COVID-19, Infectious mononucleosis — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Covid, mono
    MedDRA releases: 2024-11 · check-in free text available
  8. 2022-10-01
    Report sent to call center — 12 months, dose 3
    Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  9. 2022-10-04

Vaccinations

DoseDateManufacturerCo-administered
12021-01-08Pfizer-BioNTech No
22021-01-29Pfizer-BioNTech No
32021-10-01Pfizer-BioNTech No

Call center

1 call center case

1 unsuccessful

See the call center timeline

Free text

Release 12 — 12 months, dose 3

2022-10-01

Symptoms: Covid, mono

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDCOVID-19 · · ✓
SDInfectious mononucleosis · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release